By Amina Niasse and Sriparna Roy June 12 (Reuters) - Cigna's pharmacy benefits services unit Express Scripts requested on ...

Cigna’s (CI) Express Scripts is offering a new prescription drug program that limits costs to consumers, acting as a safety net for millions of newly uninsured individuals. With at least 30 million ...

Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...

Express Scripts is putting companies offering cutting-edge treatments into a "formulary" of recommendations for insurance plans and doctors. The hope is to make it easier for digital health companies ...

The company that manages Tricare's pharmacy benefits will give thousands of independent and community pharmacies that left the network last month an opportunity to rejoin -- but it's unclear whether ...

UPDATE: Dec. 20, 2018: Cigna's acquisition of Express Scripts closed Thursday as planned, the companies announced. The lines are now blurring between pharmacy benefit managers, which used to operate ...

Add Yahoo as a preferred source to see more of our stories on Google. Two dozen Democrat and Republican lawmakers have raised issues about Express Scripts, the company that oversees the U.S.

Pharmacy benefit manager Express Scripts' lawsuit claiming the Federal Trade Commission defamed the company and industry as greedy in a scathing report will go nowhere as the government is generally ...

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action "The fact is that in the unlikely event the ...

Shares of the top pharmacy benefits manager (PBM) Express Scripts Holding Company (NASDAQ: ESRX) rose by 15.8% in December, according to data from S&P Global Market Intelligence. The catalyst?

Express Scripts Holding Co. agreed to pay $3.6 billion to acquire closely held EviCore Healthcare, a company that preapproves scans and other costly medical tests for health plans. The deal comes as ...

FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and patients Information about Express ...